AC Immune
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AC Immune and other ETFs, options, and stocks.About ACIU
AC Immune SA is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutic and diagnostic products for neurodegenerative diseases. It leverages proprietary technology platforms to discover, design, and develop novel, proprietary medicines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding.
CEOAndrea Pfeifer
CEOAndrea Pfeifer
Employees172
Employees172
HeadquartersLausanne, Vaud
HeadquartersLausanne, Vaud
Founded2003
Founded2003
Employees172
Employees172
ACIU Key Statistics
Market cap293.86M
Market cap293.86M
Price-Earnings ratio-3.55
Price-Earnings ratio-3.55
Dividend yield—
Dividend yield—
Average volume223.88K
Average volume223.88K
High today$3.04
High today$3.04
Low today$2.93
Low today$2.93
Open price$2.93
Open price$2.93
Volume53.10K
Volume53.10K
52 Week high$4.00
52 Week high$4.00
52 Week low$1.43
52 Week low$1.43
Stock Snapshot
AC Immune(ACIU) stock is priced at $2.99, giving the company a market capitalization of 293.86M. It carries a P/E multiple of -3.55.
On 2025-11-29, AC Immune(ACIU) stock moved within a range of $2.93 to $3.04. With shares now at $2.99, the stock is trading +2.0% above its intraday low and -1.6% below the session's peak.
Trading volume for AC Immune(ACIU) stock has reached 53.1K, versus its average volume of 223.88K.
The stock's 52-week range extends from a low of $1.43 to a high of $4.00.
The stock's 52-week range extends from a low of $1.43 to a high of $4.00.
People also own
Based on the portfolios of people who own ACIU. This list is generated using Robinhood data, and it’s not a recommendation.